Biopharmaceutical manufacturers will be supported in guaranteeing product quality and reducing costs, through an upcoming webinar to be delivered by Parker Bioscience Filtration.
Taking place on June 4, the webinar, entitled Improving Sterilisation in the Biopharmaceutical Industry, will be presented by Paul Hymus, product manager (filtration) at Parker Bioscience Filtration.
The webinar will focus on optimizing biopharmaceutical filtration processes and it will examine the advantages of sterile filtration as the biopharmaceutical industry continues to move from stainless steel to single-use.
It will help participants to learn how to choose the right filtration solutions for their bioprocessing applications and enhance their understanding of how filters are developed.
The webinar will provide guidance on filter integrity testing and how this is linked to filter validation, and offer troubleshooting tips on the filtration process.
Registration for the webinar is free.
Parker Bioscience Filtration provides integrated bioprocessing solutions that speed up development times, and increase efficiency and safety to enable reproducible quality. Incorporating the expertise within SciLog® and domnick hunter, Parker Bioscience Filtration combines filtration, single-use fluid-handling systems and sensors into automated single-use solutions.
Paul Hymus, product manager (filtration) at Parker Bioscience Filtration, said: “Sterile filtration has evolved a great deal since it was first introduced into bioprocessing more than 60 years ago. Filters have moved from cartridge to capsule format and biopharmaceutical manufacturers can now choose from multiple filter membranes. The landscape is more complex and using filters which aren’t fit for purpose can have a major impact on production – and potentially lead to contamination events.
“It’s therefore crucial that biopharmaceutical manufacturers are supported in selecting the most effective filtration system and optimizing filtration processes in order to guarantee the quality of their products and to reduce the costs associated with poor filter performance – for instance increased spend on replacement filters or batch contamination.
“This webinar will help those working across biopharmaceutical manufacturing – including purification scientists, operations managers, facilities managers, automation engineers and downstream and upstream process development technicians – to gain a more comprehensive understanding of sterile filtration, and to put that into practice in their own environments.”
Parker Bioscience Filtration is part of Parker Hannifin, the world's leading diversified manufacturer of motion and control technologies and systems. It designs, supplies and delivers whole systems for both upstream and downstream pharmaceutical and biopharmaceutical manufacturing.
With another manufacturing site in Oxnard, California, Parker Bioscience Filtration supports companies both locally and globally in improving process control, efficiency and supply chain security throughout their production and packaging processes.
The Improving Sterilisation in the Biopharmaceutical Industry will take place on June 4, 2019 at 3pm London time/10am New York time. To register and for more information visit https://www.business-review-webinars.com/webinar/Pharma/Improving_Sterilising_Filtration_in_the_Biopharmaceutical_Industry-Gxyzr2bw
For more information, visit www.parker.com/bioscience.
About Parker Hannifin
Parker Hannifin is a Fortune 250 global leader in motion and control technologies. For 100 years the company has engineered the success of its customers in a wide range of diversified industrial and aerospace markets. For more information, visit www.parker.com.
SOURCE: Parker Bioscience